Mrv0541 07211320122D 9 9 0 0 0 0 999 V2000 -2.3866 3.1232 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.1011 2.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1011 1.8857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3866 1.4732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6721 1.8857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6721 2.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9577 1.4732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2432 1.8857 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9577 0.6482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 6 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 5 7 1 0 0 0 0 7 8 1 0 0 0 0 7 9 2 0 0 0 0 M END > DB08848 > drugbank > OC(=O)C1=CCCNC1 > InChI=1S/C6H9NO2/c8-6(9)5-2-1-3-7-4-5/h2,7H,1,3-4H2,(H,8,9) > QTDZOWFRBNTPQR-UHFFFAOYSA-N > C6H9NO2 > 127.1412 > 127.063328537 > 3 > 18 > -0.001247844861721803 > 12.847179589380715 > 1 > 2 > 0 > 0 > 1,2,5,6-tetrahydropyridine-3-carboxylic acid > -2.24 > -2.5854339168739813 > -0.62 > 0 > 0 > 1 > 0 > 3.571960410080911 > 9.767888308840712 > 49.33 > 33.7972 > 1 > 1 > 3.08e+01 g/l > biotin > 0 > DB08848 > experimental > Guvacine > Guvacine hydrochloride $$$$